The proof is in the purification! Against the COVID-19 pandemic gripping the United States and Canada, and as we enter the official flu season, GreenTech Environmental is thrilled to release laboratory test results of its personal air purification product, the pureAir SOLO against the swine flu.
While global scientists continue to develop early-stage research on novel coronavirus (SARS-CoV-2), the virus that causes COVID-19 disease, testing on other flu viruses, such the H1N1 virus, can supply invaluable insight into potential mitigation of coronavirus.
To supply science-based facts about ionization air purification and their other forms of active air purification, we have commissioned independent third-party laboratory testing for our products. The first of these tests provides consumers with an additional layer of security during this particularly difficult flu season.
The results show remarkable efficacy of ionized air against the H1N1 swine flu virus. Our wearable ionization device, the pureAir SOLO, emits positively charged ions, reduces virus exposure up to 99%.
The pureAir SOLO, and the more recently released pureAir PERSONAL, work by emitting ions which actively neutralize volatile organic compounds (VOC) including bacteria, viruses, and mold. The ions surround the wearer’s ambient air and effectively act as a barrier that protect against VOCs.
“Scientists have long known ionization is one of nature’s most effective defenders against airborne mold, bacteria, and viruses.” said GreenTech Environmental’s CEO Allen Johnston.
“These independent results prove our devices are an effective tool in virus mitigation and we hope consumers use them as an effective tool in flu mitigation to keep themselves and family members shielded against the flu this holiday season,”
We remind all air purification customers that devices which use “active” technologies such as ionization, including the pureAir SOLO and pureAir PERSONAL, are effective only when in use and we always recommend that consumers continue to follow all CDC guidelines as part of virus mitigation.